Pharma
The science behind the therapy that catapulted a biopharma’s stock 1,400% and counting
Spruce Biosciences saw its stock soar after months of decline, thanks to a new drug for a rare disease.
Rare Disease Research
Stay updated on Rare Disease Research trends and industry impact. Healthcare Brew provides the latest news and professional analysis on Rare Disease Research's role in Drug Discovery & Development and Pharma.
Navigate the healthcare industry
Healthcare Brew covers pharmaceutical developments, health startups, the latest tech, and how it impacts hospitals and providers to keep administrators and providers informed.
By subscribing, you accept our Terms & Privacy Policy.
